SAPA Investment Forum @JPM Week – Global Innovation
Registration is closed due to being fully booked. No on-site registration.
Thank you for your understanding.
*Please note: Registration information will be shared with Deloitte for security check to access the venue.
The Sino-American Pharmaceutical Professionals Association (SAPA) will host its second in-person Healthcare Global Innovation Forum during the 41st week of JP Morgan Healthcare Conference in San Francisco, California. It is a great opportunity:
- To meet with investors, business consultants and legal professionals, and hear their perspectives on market sentiment and outlook as well as wisdoms in business transactions.
- To network with executives at Life Science companies and learn their corporate strategies to weather the market downturn.
- To showcase company capabilities and enhance visibility with prospective business partners.
Time:
Monday, January 9th, 2023, 1-5:30 pm
Location:
Deloitte Office, 555 Mission St, San Francisco, CA 94105
Agenda:
- 1:00-1:30pm, Check in and Networking
- 1:30-1:40pm, Welcome Remarks
- Jack Wu, PhD, MBA, Head, Business Development, Search & Evaluation, Antengene Corp.; SAPA President-Elect
- Lili Zheng, Partner, International Tax, AP Cross-Border Services Leader, Deloitte Tax LLP
- 1:40-2:00pm, Keynote: Optionality – Navigating the Dynamic Environment for M&A and Cross Broader Partnerships
- Sheryl Jacobson, Principal, Medtech Practice Leader, Deloitte Consulting LLP
- 2:00-3:00 pm, Panel I: Investment and Business Opportunities in Life Sciences in the Post-Pandemic Era
- Moderator: Wansheng Jerry Liu, PhD, JD, Partner and Chair of China Practice, Fox Rothschild LLP; SAPA President (2019-2020)
- Matthew Kittay, JD, Partner and Co-Chair of M&A Practice, Fox Rothschild LLP
- Brad Loncar, CEO, Loncar Investments
- Albert Wong, CEO, Hong Kong Science and Technology Parks
- Hongjian Zhang, PhD, CEO, Viva Star Biosciences (Suzhou) Co., Ltd.
- Lili Zheng, Partner, International Tax, AP Cross-Border Services Leader, Deloitte Tax LLP
- 3:00-4:00 pm, Panel II: Global Collaboration: A Competitive Advantage in Advancing Innovation
- Moderator: Xiaodong Chen, PhD, Director of CMC Operations, Roivant Sciences; SAPA President (2021-2022)
- BoB Ai, PhD, MBA, Founder and Managing Partner, Goby Global LLC
- Charlene Liao, PhD, Founder, CEO and Chair of the Board, Immune-Onc
- Jingsong Wang, MD, CEO, Harbour BioMed
- Zhenhua Wu, PhD, Founder and CEO, Exegenesis Bio Inc.
- Li Yan, MD, CMO, Brii Biosciences
- 4:00-5:30 pm, Networking Reception
Title Sponsor: 
Reception Sponsor:
For sponsorship opportunities in SAPA events, please contact SAPA fundraising team: fundraising@sapaweb.org